Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Muneharu Doi is active.

Publication


Featured researches published by Muneharu Doi.


Applied Microbiology and Biotechnology | 1993

Scale-up of purine nucleoside fermentation from a shaking flask to a stirred-tank fermentor

Yasuhiro Sumino; Koji Sonoi; Muneharu Doi

Scaling-up purine nucleoside fermentation by a mutant strain of Bacillus subtilis from a shaking flask to a stirred-tank fermentor was attempted. The dimensions and the operating conditions of the stirred tank were determined in order to satisfy the optimum conditions of O2 transfer and power consumption per unit volume for the shaking flask. When the purine nucleoside fermentation was carried out in the stirred-tank fermentor under these conditions, in which the temperature simulated that in the shaking flask, the total amount of purine nucleosides produced was almost the same as that in the shaking flask, but the accumulation ratio of guanosine to total nucleotides was different from that in the flask. Since urea could not be utilized so efficiently in the stirred-tank fermentor, the NHp+f4 concentration and the pH of the culture broth were lower than those in the shaking-flask culture during fermentation. The activity of inosine monosphosphate dehydrogenase and the accumulation ratio were significantly affected by the NHp+f4 concentration. When the pH of the stirred-tank culture was maintained at 6.9 by ammonia water to keep the NHp+f4 level higher, the ratio was improved to the same level as that observed in the shaking-flask culture. The fermentation heat calculated from the shaking-flask data and its pattern of change were similar to those in the stirred-tank fermentor.


Bioscience, Biotechnology, and Biochemistry | 1996

Effects of Homoserine Dehydrogenase Deficiency on Production of Cytidine by Mutants of Bacillus subtilis.

Satoru Asahi; Yutaka Tsunemi; Muneharu Doi

A homoserine-requiring mutant, Bacillus subtilis strain No. 615, was isolated from a cytidine-producing mutant strain No. 515. The homoserine dehydrogenase activity of strain No. 615 was reduced to less than 1/50 of that of No. 515. Strain No. 615 accumulated 23.5 mg/ml cytidine in a medium containing 16% glucose, and strain No. 515 accumulated 18.8 mg/ml cytidine under the same conditions. The effects of glucose concentration on cytidine production were examined, and strain No. 615 accumulated 30.2 mg/ml cytidine in a medium containing 20% glucose.


Applied Microbiology and Biotechnology | 1989

Mechanism of uridine production by Bacillus subtilis mutants

Muneharu Doi; Satoru Asahi; Yutaka Tsunemi; Shun-ichi Akiyama

SummaryPyrimidine analogue-resistant mutants of Bacillus subtilis were found to produce a large amount of uridine. One of them accumulated 55 mg/ml of uridine in culture medium. The changes in enzymes involved in the metabolism of uridine 5′-monophosphate (UMP) were examined with this mutant. All six enzymes of de novo UMP biosynthesis were completely free from regulation by uridine compounds, and the activities of these enzymes were 16- to 30-fold higher than those of the enzymes of the parental strain. In the mutant strain, the level of uridine phosphorylase, responsible for converting uridine to uracil, was extremely low, compared with that of the parental strain. No apparent change was observed between the strains in the activity of UMP dephosphorylation or uracil phosphoribosyltransferase. The implication of these findings is discussed in relation to the overproduction of uridine by the mutant.


Agricultural and biological chemistry | 1972

Microbial Production of l-Glutamic Acid by Glycerol Auxotrophs

Yoshio Nakao; Masakazu Kikuchi; Masaru Suzuki; Muneharu Doi

To establish a novel process for the production of l-glutamic acid from n-paraffins, a glycerol auxotroph GL-21, a new type mutant, was successfully obtained from Corynebacterium alkanolyticum No. 314 by treatment with N-methyl-N′-nitro-N-nitrosoguanidine. This auxotroph required glycerol for its growth regardless of the carbon source used.At 72 hr, this mutant GL-21 produced about 40 mg/ml of l-glutamic acid from n-paraffins in the culture broth at 0.01 per cent addition of glycerol in the absence of penicillin.A thiamine auxotroph, a biotin auxotroph and an oleic acid auxotroph were also obtained by a similar technique, but these auxotrophs were found to be inapplicable for the production of l-glutamic acid from n-paraffins.


Nature Biotechnology | 1986

Cloning of the Bacillus Subtilis IMP Dehydrogenase Gene and its Application to Increased Production of Guanosine

Kenichiro Miyagawa; Hiroyuki Kimura; Kazuo Nakahama; Masakazu Kikuchi; Muneharu Doi; Shun-ichi Akiyama; Yoshio Nakao


Agricultural and biological chemistry | 1972

Microbial Production of L-Glutamic Acid by Glycerol Auxotrophs Part I

Yoshio Nakao; Masakazu Kikuchi; Masaru Suzuki; Muneharu Doi


Archive | 1984

Dna and its use

Kenichiro Miyagawa; Kazuo Nakahama; Masakazu Kikuchi; Muneharu Doi


Archive | 1974

Method for the production of D-ribose

Ken-ichi Sasajima; Muneharu Doi; Teruo Fukuhara; Akira Yokota; Yoshio Nakao; Masahiko Yoneda


Agricultural and biological chemistry | 1989

Regulation of Pyrimidine Nucleotide Biosynthesis in Cytidine Deaminase-negative Mutants of Bacillus subtilis

Satoru Asahi; Muneharu Doi; Yutaka Tsunemi; Shun-ichi Akiyama


Archive | 1983

Method of producing inosine and/or guanosine

Kenichiro Miyagawa; Muneharu Doi; Shun-ichi Akiyama

Collaboration


Dive into the Muneharu Doi's collaboration.

Top Co-Authors

Avatar

Satoru Asahi

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Yoshio Nakao

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Yutaka Tsunemi

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Masakazu Kikuchi

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Shun-ichi Akiyama

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Masaru Suzuki

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Hideo Fukuda

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Akira Yokota

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Ken-ichi Sasajima

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Kenichiro Miyagawa

Takeda Pharmaceutical Company

View shared research outputs
Researchain Logo
Decentralizing Knowledge